Stony Brook University Cancer Center is creating a one-of-a-kind metabolomics and imaging translational research program that will transform the future of cancer knowledge and care.
Two incredibly generous gifts from Kavita and Lalit Bahl, totaling 13.75 million, will allow us to establish Stony Brook as home to The Kavita and Lalit Bahl Center for Metabolomics and Imaging. We are honored they have entrusted us to propel cancer treatment and research to the next level and beyond.
Their initial gift of $3.5 million provided for the purchase of a cyclotron. This particle accelerator is used to create novel tracer molecules for PET scanning, which allows advanced diagnostics through molecular imaging within the human body.
Now, the Bahls have followed up with an additional $10.25 million pledge, which will support the Stony Brook Cancer Center in conducting revolutionary research and recruit top experts in all related fields. New faculty will include an oncologic imaging researcher, a matrix-assisted laser desorption ionization (MALDI) researcher and a magnetic resonance (MR) spectroscopy researcher.
The Bahls’ gifts will enable Stony Brook to perform cutting-edge personalized cancer research and diagnostic imaging breakthroughs, powering the evolution of individualized cancer care into the cancer treatment of tomorrow. The gifts bring to life the Bahl family’s vision for defeating cancer. Without such generous private philanthropy, vital research tools such as the cyclotron might not be available to our faculty.
Stony Brook Medicine already has a strong foundation in place, with widely respected researchers in the fields of metabolomics, cancer biology, medical imaging and computational oncology. Drawing on our strengths as part of Stony Brook University, our multidisciplinary teams are uniquely positioned to conduct pioneering, transformative cancer research.
Stony Brook University School of Medicine laboratories and other University laboratories will conduct research for the Bahl Center. Permanent physical space will be located in the Medical and Research Translation (MART) building upon opening in 2018.
The totality of the Bahls’ two gifts, both generous and visionary, will have a decades-long impact on cancer research, medical treatments and patient care. Together we will conquer one of the last critical frontiers is cancer metabolism and lipids research to transform cancer care.
Yusuf Hannun, MD
Director, Stony Brook University Cancer Center
Vice Dean for Cancer Medicine
Joel Strum Kenny Professor in Cancer Research
Lina Obeid, MD
Professor of Medicine and Vice Dean for Research, Stony Brook University School of Medicine